Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 6573 participants.
Also called NCT05478304
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 6,573 participants
- Registry
-
NCT05478304
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Austria, Belgium, Canada, Czechia, Germany, New Zealand, Spain, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05478304. Randomized; triple masking; primary purpose treatment. Start 2023-01-25 (actual); primary completion 2031-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
- Acronym
- LeAAPS
- Condition
- Ischemic Stroke
- Condition
- Systemic Embolism
- Intervention (Device)
- AtriClip LAA Exclusion System
- Lead sponsor
- AtriCure, Inc.
- Collaborator
- Population Health Research Institute
Record details
- Record id
cardio:ct-nct05478304- Content hash
e11c82ffdbc9405e53ea2ff1930ef7424f9481bb0928dea10ca8c192580645dd